Development Pipeline
Detailed information on the research project currently underway. We encourage you to bookmark these pages and check back often. Updates will be added periodically with new information on status, newly-released data, and clinical trial results. Back to New Hair Loss Research Pipeline
Hair Stimulating Complex (HSC) is an injectable treatment for hair loss. The injected solution is produced by neonatal cells grown under simulated embryonic conditions of hypoxia (3-5% oxygen) and suspension. Under these conditions, the cells become multipotent. There is a significant upregulation of growth factors which have been shown to be important in hair viability.
The proteins within HSC, including KGF, VEGF, and follistatin, are involved in signaling stem cells in the body, and have been shown to be key in hair formation and the stimulation of resting hair follicles. Follistatin in particular has been linked to hair follicle stem cell proliferation.
www.histogen.com
Innovative Developments in Regenerative Medicine
I am text block. Click edit button to change this text. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.
09-29-16: Histogen Signs Deal with China Distributor 08-18-16: Interview with Dr. Gail Naughton – Status update on HSC Research 08-15-16: Histogen Secures $6m Investment
